455 related articles for article (PubMed ID: 3652025)
1. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.
Creasman WT; Morrow CP; Bundy BN; Homesley HD; Graham JE; Heller PB
Cancer; 1987 Oct; 60(8 Suppl):2035-41. PubMed ID: 3652025
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of different surgical approaches in the treatment of endometrial cancer at FIGO stage I.
Candiani GB; Belloni C; Maggi R; Colombo G; Frigoli A; Carinelli SG
Gynecol Oncol; 1990 Apr; 37(1):6-8. PubMed ID: 2323614
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastasis in early endometrium cancer.
Ayhan A; Yarali H; Urman B; Günalp S; Yüce K; Ayhan A; Havlioglu S
Aust N Z J Obstet Gynaecol; 1989 Aug; 29(3 Pt 2):332-5. PubMed ID: 2619683
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
Creasman WT; Disaia PJ; Blessing J; Wilkinson RH; Johnston W; Weed JC
Am J Obstet Gynecol; 1981 Dec; 141(8):921-9. PubMed ID: 7315922
[TBL] [Abstract][Full Text] [Related]
5. Extrauterine spread in endometrial carcinoma clinically confined to the uterus.
Chen SS
Gynecol Oncol; 1985 May; 21(1):23-31. PubMed ID: 3988126
[TBL] [Abstract][Full Text] [Related]
6. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
[TBL] [Abstract][Full Text] [Related]
7. [Surgical therapy of endometrial cancer].
Büttner HH
Zentralbl Gynakol; 1987; 109(7):432-7. PubMed ID: 3617990
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
9. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
[TBL] [Abstract][Full Text] [Related]
10. Endometrial carcinoma: the relevance of cervical cytology.
DuBeshter B; Warshal DP; Angel C; Dvoretsky PM; Lin JY; Raubertas RF
Obstet Gynecol; 1991 Mar; 77(3):458-62. PubMed ID: 1992417
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in endometrial cancer.
Rakar S; Kovacic J
Eur J Gynaecol Oncol; 1990; 11(3):233-5. PubMed ID: 2209644
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal lymph node metastases in Stage I carcinoma of the endometrium: correlation with risk factors.
Chen SS; Lee L
Gynecol Oncol; 1983 Dec; 16(3):319-25. PubMed ID: 6654176
[TBL] [Abstract][Full Text] [Related]
13. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
Kadar N; Homesley HD; Malfetano JH
Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
[TBL] [Abstract][Full Text] [Related]
14. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
15. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal spread and its prognostic impact in stages I and II (FIGO) endometrial carcinoma.
Sakuragi N; Tanaka T; Satoh C; Nishiya M; Ohkouchi T; Tsumura N; Takeda N; Hirahatake K; Sagawa T; Ohkubo H
Asia Oceania J Obstet Gynaecol; 1991 Sep; 17(3):193-201. PubMed ID: 1953428
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of gross myometrial invasion with endometrial cancer.
Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
[TBL] [Abstract][Full Text] [Related]
18. Stage II endometrial adenocarcinoma. Memorial Hospital for Cancer, 1949-1965.
Homesley HD; Boronow RC; Lewis JL
Obstet Gynecol; 1977 May; 49(5):604-8. PubMed ID: 850578
[TBL] [Abstract][Full Text] [Related]
19. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
